Search research articles
Contact Us
Filters
Showing results (121-130 of 161) with videos related to
Page
of 17
Sort By:
Korean Journal of Urology
|
December 24, 2013
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy
Sahyun Pak, Sejun Park, Jeman Ryu, et al.
Scientific Reports
|
May 7, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes
Dongrul Shin, Bumjin Lim, Cheryn Song, et al.
Journal of Surgical Oncology
|
October 13, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome
Teak Jun Shin, Cheryn Song, Chang Wook Jeong, et al.
BMC Cancer
|
March 11, 2018
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Myong Kim, Cheryn Song, In Gab Jeong, et al.
Urology
|
October 31, 2006
Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy
Cheryn Song, Jae Y Ro, Moo-Song Lee, et al.
Investigational New Drugs
|
October 21, 2011
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum
Jae-Lyun Lee, Jin-Hee Ahn, Se Hoon Park, et al.
BMC Cancer
|
March 29, 2025
Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study
Jae Ho Lee, Hyun Young Lee, Ji Eun Park, et al.
Cancer Chemotherapy and Pharmacology
|
March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor
Inkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
Cancer Chemotherapy and Pharmacology
|
December 22, 2015
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma
Dong-Hoe Koo, Inkeun Park, Jin-Hee Ahn, et al.
Yonsei Medical Journal
|
April 6, 2012
Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations
Seok-Soo Byun, Sangchul Lee, Sang Eun Lee, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 161) with videos related to
Sort By:
Page
of 17
Korean Journal of Urology
|
December 24, 2013
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy
Sahyun Pak, Sejun Park, Jeman Ryu, et al.
Scientific Reports
|
May 7, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes
Dongrul Shin, Bumjin Lim, Cheryn Song, et al.
Journal of Surgical Oncology
|
October 13, 2020
Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome
Teak Jun Shin, Cheryn Song, Chang Wook Jeong, et al.
BMC Cancer
|
March 11, 2018
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Myong Kim, Cheryn Song, In Gab Jeong, et al.
Urology
|
October 31, 2006
Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy
Cheryn Song, Jae Y Ro, Moo-Song Lee, et al.
Investigational New Drugs
|
October 21, 2011
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum
Jae-Lyun Lee, Jin-Hee Ahn, Se Hoon Park, et al.
BMC Cancer
|
March 29, 2025
Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study
Jae Ho Lee, Hyun Young Lee, Ji Eun Park, et al.
Cancer Chemotherapy and Pharmacology
|
March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor
Inkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
Cancer Chemotherapy and Pharmacology
|
December 22, 2015
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma
Dong-Hoe Koo, Inkeun Park, Jin-Hee Ahn, et al.
Yonsei Medical Journal
|
April 6, 2012
Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations
Seok-Soo Byun, Sangchul Lee, Sang Eun Lee, et al.
Page
of 17